Your challenge: Planning a new product launch?
With an approved drug more likely to fail than succeed in repaying its R&D costs, planning the best launch strategy is hyper-critical.
Are you:
- confident your communication messages will resonate?
- engaged with the right audience?
- certain which channels will drive growth?
- facing launch in a crowded market?
- required to deliver upfront ROI to cover R&D costs or compensate for patent expiry?
- reporting on the effectiveness of each stage of the launch plan?
Our solution
Eularis 94.8 will ensure that your plan is completely robust by allowing you to adjust and consider all the relevant market drivers and resultant effects before your product hits the market.
You’ll be able to:
- identify the real market drivers in your particular disease area
- divert your spend to enforce drivers with the greatest influence on financial impact
- highlight the perceived strengths and weaknesses of current and future competitors
- differentiate your brand even before it is launched
- test whether particular claims and product attributes are actually driving the market
- analyze whether you have more work to do to influence your audience